Stable Growth Predicted in Aspiration and Biopsy Needles Market in Coming Years

One of the most important factors leading to the rising demand for aspiration and biopsy needles is the increasing prevalence of cancer across the world. According to the World Health Organization (WHO), the number of people who died from cancer stood at 9.6 million in 2018. Furthermore, the number of people suffering from malignant tumors will increase from 12.7 million in 2008 to 21.4 million in 2030, which will considerably boost the demand for aspiration and biopsy needles, on account of the fact that biopsy and aspiration procedures are extensively used for studying the nature of tumors.

The other major factors contributing to the surge in the demand for aspiration and biopsy needles are the rising popularity of minimally invasive surgeries, soaring healthcare expenditure in several countries, and rapid technological innovations in the devices used for disease diagnosis. Due to these factors, the global aspiration and biopsy needles market size is predicted to increase from $801.5 million in 2019 to $1,717.9 million in 2030. The market is expected to progress at a CAGR of 7.2% during the forecast period (2020–2030).

For More Information Aspiration and Biopsy Needles Market Report 

Geographically, the highest usage of aspiration and biopsy needles was observed in North America in 2019, mainly due to the rising awareness in the region about the early cancer diagnosis processes, soaring healthcare spending, and surging number of devices being granted approval by the USFDA. The fastest growth in the adoption of aspiration and biopsy needles is expected to be witnessed in the Asia-Pacific (APAC) region during the forecast period. This is primarily ascribed to the increasing pool of cancer patients and rising awareness regarding the various cancer diagnosis methods available in the region.

Therefore, owing to the rising incidence of cancer, increasing healthcare expenditure, and surging awareness amongst the people throughout the world about the various cancer diagnosis processes, the demand for aspiration and biopsy needles will observe significant growth in future.

Read More

Demand for Radiotherapy Projected to Rise in Asia-Pacific

 The number of cancer cases has been rising all across the globe over the past few years. As per the American Institute of Cancer Research, by 2030, the number of new cancer incidence is expected to reach 25 million. The prevalence of cancer is further predicted to be the highest in low and middle-income countries, including India and China. Cancer is among the most common chronic diseases around the globe, and was responsible for 9.6 million deaths in 2018, as per the World Health Organization. 

The prevalence of cancer can be decreased by providing efficient medical care at initial stage of the disease, which can be done by radiotherapy and chemotherapy. Radiotherapy is majorly used for treating cancer, reducing the risk of cancer coming back if a person goes through surgery, and relieving symptoms if the patient cannot be cured. It is considered the most effective treatment for cancer, however, its effectiveness varies from person to person. According to a report by P&S Intelligence, the global radiotherapy market is expected to generate a revenue of $17,194.4 million by 2030, increasing from $7,222.4 million in 2019, advancing at an 8.4% CAGR during the forecast period (2020–2030).  

Other than this, the demand for radiotherapy is also predicted to rise in Asia-Pacific, thereby making the region the fastest-growing radiotherapy market in the coming years. This is because of the increasing burden of cancer, rising investments by private and public organizations, and improving healthcare infrastructure. As per the Global Cancer Observatory, in 2018, 883,395 cancer cases were reported in Japan, and the number is predicted to rise to 3.5 million by 2025. 

Hence, the market is growing due to the surging prevalence of cancer across the globe.   

Read More

Wireless EV Chargers Facilitating Hassle-Free Long Drives

The International Energy Agency (IEA) reveals that the global stock of plug-in hybrid vehicles (PHEVs) , battery electric vehicle (BEVs) , and fuel cell electric vehicle (FCEVs) stood at 3,346,713 units, 6, 850,327 units, and 31,225 units, respectively, in 2020. By 2030, the stock of PHEVs, FCEVs, and BEVs will rise to 44,355,904, 1,152,588, 79,975,992, respectively 2030. Whereas, the global stock of BEV and PHEV electric buses is expected to surge from 515,400 in 2020 to 3,217,713 by 2030 and 81,898 in 2020 to 358,921 by 2030, respectively.  

Wireless EV Charging Market Outlook

   

Thus, the surging adoption of EVs will augment the need for fast charging options, owing to which the wireless EV charging market will advance at a significant rate during 2020–2030. To establish a fast EV charging infrastructure, several charging station developers are focusing on investing in research and development (R&D) in wireless technology. The installation of dynamic wireless systems on EVs allows them to be charged while on the move. Moreover, the absence of charging cables in wireless systems makes it more user-friendly than cable charging systems.

According to P&S Intelligence, Asia-Pacific (APAC) will dominate the wireless EV charging market in the foreseeable future. This will be due to the escalating EV adoption in developing countries, such as India and China, and developed countries, such as Japan. In recent years, China has emerged as an active participant in the EV charging industry, due to the rapid development of advanced inductive chargers. For example, in 2016, Zhejiang VIE Science & Technology Co. Ltd. and Evatran Group Inc. formed a joint venture to integrate PLugless, a wireless charging system of the former, into the EVs being manufactured in China.

Thus, the soaring number of EVs, owing to the mounting environmental concerns and escalating government support, will augment the installation of wireless EV chargers in the forthcoming years. 

Explore Full Report Description At: https://www.psmarketresearch.com/market-analysis/wireless-ev-charging-market

 

Read More

Surging Healthcare Expenditure Powering Sales of Prostate Cancer Treatment Devices in U.S.

 The availability of automated, efficient, and advanced clinical tools and the emergence of extremely accurate forms of medical treatment such as image-guided radiation therapy (IGRT), stereotactic radiosurgery (SRS), and brachytherapy are pushing up the demand for prostate cancer treatment devices in the U.S. For example, Accuray Incorporated developed CyberKnife S7 System, which is a device equipped with synchronization treatment delivery and real-time artificial intelligence (AI)-driven motion tracking for all stereotactic body radiation therapy (SBRT) and SRS treatments, in June 2020.

This device is the next-generation CyberKnife platform, which is a non-invasive and a robotic radiation therapy device that can treat benign and cancerous tumors all over the body, including those in prostate glands. The increasing incidence of prostate cancer is another major factor boosting the sales of prostate cancer treatment devices in the country. According to the American Cancer Society (ACS), one of the most prevalent types of cancers in male persons in the U.S. is prostate cancer. 

Additionally, the organization predicts that the country will witness as many as 191,930 new prostate cancer cases in 2020. With the increasing incidence of prostate cancer, the requirement for several types of treatment equipment such as those used in surgery, cryotherapy, and radiotherapy will surge in the coming years. The soaring number of government initiatives being launched and the surging healthcare expenditure in the country are also propelling the sales of prostate cancer treatment devices.  

The federal government spends a huge portion of the country’s GDP on healthcare every year. According to the National Health Expenditure Accounts (NHEA), in the U.S., the healthcare spending increased by 4.3% and reached $3.3 trillion in 2016. In 2017, the healthcare expenditure further rose to 5.4%. The increasing healthcare expenditure is making the management and treatment of many diseases highly affordable by reducing the prices of prostate cancer treatment devices.  

The mushrooming sales of these devices are fueling the growth of the U.S. prostate cancer treatment devices market. According to the estimates of the market research firm, P&S Intelligence, the valuation of the market would grow from $95.9 million in 2019 to $157.1 million by 2030. The market will demonstrate a CAGR of 5.6% from 2020 to 2030. Surgery, radiation, high-intensity focused ultrasound (HIFU), and cryotherapy are the main types of prostate cancer treatment devices used in the country. 

Read More

Why are Sales of Skincare Dermacosmetics Products Soaring in India?

India has witnessed rapid economic progress in recent years, which has subsequently resulted in a massive rise in the disposable income of its citizens. As per the data produced by Trading Economics, in India, the disposable income grew from $2,738.1 billion in 2018 to $2,935.9 billion in 2019. Moreover, with the country predicted to witness sharp economic growth in the coming years, the purchasing power of its citizens will further shoot up.

This will, in turn, propel the sales of skincare dermacosmetics products in the country in the coming years. Besides the increasing disposable income of people, the rising inclination of people for having a good physical appearance is also propelling the sales of skincare dermacosmetics products in the country. People are making huge investments for brightening and maintaining their skin and using products for mitigating the occurrence of acne marks and the signs of aging such as fine lines and wrinkles.

Furthermore, as per the estimates of the market research company, P&S Intelligence, the market will progress at a CAGR of 8.5% between 2020 and 2030. The major brands that sell skincare dermacosmetics products in the country are Neutrogena, Avène, L’Oréal (Skinceuticals and CeraVe), A-Derma, Galderma and Cetaphil, BIODERMA, Clinique, Sebamed, Ducray, Clarins, and Shiseido. Out of these, the demand for products developed by Avène was found to be the highest in the country in 2019. 

This was mainly because of the availability of a diverse range of products and patented technologies developed by the company for addressing various skin problems and concerns. The major application areas of skincare dermacosmetics products in the country are wrinkles and fine lines, acne, dark circles, skin repair, scars, and psoriasis. Out of these, skin repair applications are predicted to generate the highest demand for skincare dermacosmetics products in the coming years. 

Read More

Why are Sales of On-Board Chargers Rising Sharply?

The mushrooming demand for electric vehicles is encouraging electric vehicle charging system manufacturers to focus on developing technologically advanced and innovative variants. Moreover, with the surging concerns being raised over the deteriorating environmental conditions, many electric vehicle manufacturers are making huge investments in research and development (R&D) projects in order to fuel advancements in the electric vehicle technology. For instance, Fiat Chrysler Automobiles N.V. announced in July 2019 that it intends to make an investment of $788 million (EUR 700 million) for developing a manufacturing line for the newer models of its Fiat 500 minicar.

Industry Outlook for On-Board Charger

This manufacturing line will enable the production of around 80,000 units every year. These investments are causing a sharp fall in manufacturing costs, which is, in turn, leading to the production of affordable electric vehicles. This is subsequently pushing up the demand for on-board chargers. These projects have led to the development of batteries having increased power densities. Besides, the increasing deployment of alternating current (AC) charging stations in emerging economies is also fueling the expansion of the on-board charger market.

This is primarily ascribed to the deployment of numerous AC chargers, as they are majorly used at homes for charging electric vehicles. As these chargers are cheaper than the other variants, they are being preferred by people throughout the world. Some of the major on-board charger manufacturing companies across the world are NXP Semiconductors N.V., Delta-Q Corporation, Delphi Technologies PLC, Eaton Corporation plc, Delta Electronics Inc., Avid Technology Inc., Toyota Motor Corporation, Infineon Technologies AG, and LG Chem Ltd.

Hence, it can be said without any doubt that the demand for on-board chargers will surge sharply in the forthcoming years, primarily because of the growing deployment of electric vehicles and the development of technologically advanced charging systems, on account of the surging investments being made by industry players across the world. 

Explore Full Report Description At: https://www.psmarketresearch.com/market-analysis/on-board-charger-market

Read More

Optical Amplifier Market Future Trends, Prominent Players, Covid 19 Impact and Forecast by 2030

A number of factors such as the soaring infrastructural investments, rising technological advancements in wireless sensor, mounting number of data centers, burgeoning demand for data transmission without data losses for longer distances, and surging number of smart cities and smart homes will act as a growth driver for the optical amplifier market. An optical amplifier refers to a device that directly amplifies an optical signal and generates an output signal with elevated optical power without converting it to an electrical signal. 

This device has completely transformed networking and communication systems. Categories under the type segment of the optical amplifier market are Raman amplifier, earth doped fiber amplifier (EDFA), and semiconductor optical amplifier. In 2019, the EDFA category generated the highest revenue in the market, as this amplifier is an important component in long-range optical fiber communication. Due to the large gain bandwidth of EDFA, it is utilized in data channels with high data rate. 

As compared to the other amplifiers, EDFA is more reliable and has a longer lifetime. The end user segment of the optical amplifier market is classified into aerospace, industrial, healthcare, telecommunication, data center, military and defense, and others. Among these, the telecommunication category is expected to account for the largest market share, primarily on account of the rising use of optoelectronic devices, such as optical amplifiers, and optical fiber for communication medium. 

Whereas, the data center category will hold the second position in the market in the coming years, due to the surging need for multiple devices, servers, and devices, using optical amplifiers, in data centers. According to P&S Intelligence, Asia-Pacific (APAC) is expected to account for the largest share in the optical amplifier market in the coming years. This can be attributed to the increasing penetration of smartphones and expanding broadband user base in the region. 

For instance, according to the India Cellular & Electronics Association (ICEA), the number of smartphone users in India will rise from 500 million in 2019 to 829 million by 2022. ICEA also states that the average monthly data consumption of an individual will reach 18 GB by 2024.

Read More